{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anticancer activities", "Benzenesulfonamides", "Chloroquinolines"]], "OtherID": [], "CitationSubset": [], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27053947", "DateCompleted": {"Year": "2016", "Month": "04", "Day": "07"}, "DateRevised": {"Year": "2020", "Month": "09", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "04", "Day": "05"}], "ELocationID": ["18", "10.1186/s13065-016-0164-1"], "Language": ["eng"], "Journal": {"ISSN": "1752-153X", "JournalIssue": {"Volume": "10", "PubDate": {"Year": "2016"}}, "Title": "Chemistry Central journal", "ISOAbbreviation": "Chem Cent J"}, "ArticleTitle": "Novel chloroquinoline derivatives incorporating biologically active benzenesulfonamide moiety: synthesis, cytotoxic activity and molecular docking.", "Pagination": {"StartPage": "18", "MedlinePgn": "18"}, "Abstract": {"AbstractText": ["Quinoline derivatives have diverse biological activities including anticancer activity. On the other hand, many sulfonamide derivatives exhibited good cytotoxic activity. Hybrids of both moieties may present novel anticancer agents.", "Chloroquinoline incorporating a biologically active benzene-sulfonamide moieties 5-21 and diarylsulfone derivatives 22 and 23 were prepared using (E)-1-(4-((E)-7-chloro-1-methylquinolin-4(1H)-ylideneamino)phenyl)-3-(dimethyl-amino)prop-2-en-1-one 4 as strategic starting material. The structure of the newly synthesized compounds were confirmed by elemental analyses and spectral data. Compound 4 was confirmed by X-ray crystallographic analysis. The prepared compounds were evaluated for their anticancer activity against Lung, HeLa, Colorectal and breast cancer cell lines. Compounds 2, 4, 7, 11, 14 and 17 showed better or comparable activity to 2', 7'-dichlorofluorescein (DCF) as reference drug. Molecular docking of the active compounds on the active site of PI3K enzyme was performed in order to explore the binding mode of the newly synthesized compounds.", "Compounds 2, 4, 7, 11, 14 and 17 are novel quinoline derivatives that may represent good candidates for further evaluations as anticancer agents. The mechanism of action of these compounds could be through inhibition of PI3K enzyme.Graphical abstractCompound 17 on the active site of PI3K."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh, 11451 Saudi Arabia ; Department of Drug Radiation Research, National Center for Radiation Research and Technology, Nasr City, Cairo, 113701 Egypt."}], "LastName": "Ghorab", "ForeName": "Mostafa M", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh, 11451 Saudi Arabia."}], "LastName": "Alsaid", "ForeName": "Mansour S", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh, 11451 Saudi Arabia."}], "LastName": "Al-Dosari", "ForeName": "Mohammed S", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt."}], "LastName": "Nissan", "ForeName": "Yassin M", "Initials": "YM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal, Aromatic and Poisonous Plants Research Center (MAPPRC), College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh, 11451 Saudi Arabia."}], "LastName": "Al-Mishari", "ForeName": "Abdullah A", "Initials": "AA"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Chem Cent J", "NlmUniqueID": "101314213", "ISSNLinking": "1752-153X"}}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Gopal M, Shenoy S, Doddamani LS. Antitumor activity of 4-amino and 8-methyl-4-(3diethylamino propylamino)pyrimido[4\u2032,5\u2032:4,5]thieno (2,3-b) quinolines. J Photochem Photobiol B. 2003;72:69\u201378. doi: 10.1016/j.jphotobiol.2003.09.003.", "ArticleIdList": ["10.1016/j.jphotobiol.2003.09.003", "14644568"]}, {"Citation": "Kim YH, Shin KJ, Lee TG, Kim E, Lee MS, Ryu SH, Suh PG. G2 arrest and apoptosis by 2-amino-N-quinoline-8-yl-benzenesulfonamide (QBS), a novel cytotoxic compound. Biochem Pharmacol. 2005;69:1333\u20131341. doi: 10.1016/j.bcp.2004.12.019.", "ArticleIdList": ["10.1016/j.bcp.2004.12.019", "15826604"]}, {"Citation": "Zhao YL, Chen YL, Chang FS, Tzeng CC. Synthesis and cytotoxic evaluation of certain 4-anilino-2-phenylquinoline derivatives. Eur J Med Chem. 2005;40:792\u2013797. doi: 10.1016/j.ejmech.2005.03.008.", "ArticleIdList": ["10.1016/j.ejmech.2005.03.008", "16122581"]}, {"Citation": "Wall ME, Wani MC, Cook CE, Palmer KH, McPhail AT, Sim GA. plant antitumor agents. I. the isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata. J Am Chem Soc. 1966;88:3888\u20133890. doi: 10.1021/ja00968a057.", "ArticleIdList": ["10.1021/ja00968a057"]}, {"Citation": "Ma ZZ, Hano Y, Nomura T, Chen YJ. Two new pyrroloquinzolinoquinoline alkaloids from Peganum nigellastrum. Heterocycles. 1997;46:541\u2013546. doi: 10.3987/COM-97-S65.", "ArticleIdList": ["10.3987/COM-97-S65"]}, {"Citation": "Kobayash J, Cheng J, Nakamura H, Ohizumi Y, Hirata Y, Sasaki T, Ohta T, Nozoe S. Ascididemin, a novel pentacyclic aromatic alkaloid with potent antileukemic activity from the okinawan tunicate Didemnum sp. Tetrahedron Lett. 1988;29:1177\u20131180. doi: 10.1016/S0040-4039(00)86681-2.", "ArticleIdList": ["10.1016/S0040-4039(00)86681-2"]}, {"Citation": "Utsugi T, Aoyagi K, Asao T, Okazaki S, Aoyagi Y, Sano M, Wierzba K, Yamada Y. Antitumor activity of a novel quinoline derivative, TAS-103, with inhibitory effects on topoisomerases I and II. Jpn J Cancer Res. 1997;88:992\u20131002. doi: 10.1111/j.1349-7006.1997.tb00320.x.", "ArticleIdList": ["10.1111/j.1349-7006.1997.tb00320.x", "PMC5921285", "9414662"]}, {"Citation": "Jonckers TH, van Miert S, Cimanga K, Bailly C, Colson P, De Pauw-Gillet MC, van den Heuvel H, Claeys M, Lemi\u00e8re F, Esmans EL, Rozenski J, Quirijnen L, Maes L, Dommisse R, Lemi\u00e8re GL, Vlietinck A, Pieters L. Synthesis, cytotoxicity, and antiplasmodial and antitrypanosomal activity of new neocryptolepine derivatives. J Med Chem. 2002;45:3497\u20133508. doi: 10.1021/jm011102i.", "ArticleIdList": ["10.1021/jm011102i", "12139461"]}, {"Citation": "Gireesh KK, Rashid A, Chakraborti S, Panda D, Manna T. CIL-102 binds to tubulin at colchicine binding site and triggers apoptosis in MCF-7 cells by inducing monopolar and multinucleated cells. BiochemPharmacol. 2012;84:633\u2013645.", "ArticleIdList": ["22705644"]}, {"Citation": "Peczy\u0144ska-Czoch W, Pognan F, Kaczmarek L, Boraty\u0144ski J. Synthesis and structure-activity relationship of methyl-substituted indolo[2,3-b]quinolines: novel cytotoxic, DNA topoisomerase II inhibitors. J Med Chem. 1994;37:3503\u20133510. doi: 10.1021/jm00047a008.", "ArticleIdList": ["10.1021/jm00047a008", "7932579"]}, {"Citation": "Martirosyan A, Rahim-Bata R, Freeman A, Clarke C, Howard R, Strobl J. Differentiation-inducing quinolines as experimental breast cancer agents in the MCF-7 human breast cancer cell model. Biochem Pharmacol. 2004;68:1729\u20131738. doi: 10.1016/j.bcp.2004.05.003.", "ArticleIdList": ["10.1016/j.bcp.2004.05.003", "15450938"]}, {"Citation": "M\u00f3l W, Matyja M, Filip B, Wietrzyk S. Synthesis and antiproliferative activity in vitro of novel (2-butynyl)thioquinolines. Bioorg Med Chem. 2008;16:8136\u20138141. doi: 10.1016/j.bmc.2008.07.047.", "ArticleIdList": ["10.1016/j.bmc.2008.07.047", "18682326"]}, {"Citation": "Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat. Rev. Drug. Discov. 2008;7:168\u2013181. doi: 10.1038/nrd2467.", "ArticleIdList": ["10.1038/nrd2467", "18167490"]}, {"Citation": "Supuran CT, Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem. 2007;15:4336\u20134350. doi: 10.1016/j.bmc.2007.04.020.", "ArticleIdList": ["10.1016/j.bmc.2007.04.020", "17475500"]}, {"Citation": "Supuran CT, Scozzafava A, Casini A. Carbonic anhydrase inhibitors. Med Res Rev. 2003;23:146\u2013189. doi: 10.1002/med.10025.", "ArticleIdList": ["10.1002/med.10025", "12500287"]}, {"Citation": "Knight SD, Schmidt SJ (2008) Smithkline Beecham corporation. US Patent: US 8138347"}, {"Citation": "Smart BE. Fluorine substituent effects (on bioactivity) J Fluor Chem. 2001;109:3\u201311. doi: 10.1016/S0022-1139(01)00375-X.", "ArticleIdList": ["10.1016/S0022-1139(01)00375-X"]}, {"Citation": "Al-Dosari MS, Ghorab MM, Alsaid MS, Nissan YM. Discovering some novel 7-chloroquinolines carrying a biologically active benzenesulfonamide moiety as a new class of anticancer agents. Chem Pharm Bull. 2013;61:50\u201358. doi: 10.1248/cpb.c12-00812.", "ArticleIdList": ["10.1248/cpb.c12-00812", "23302586"]}, {"Citation": "Al-Dosari MS, Ghorab MM, Alsaid MS, Nissan YM, Ahmed AB. Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety. Eur J Med Chem. 2013;69:373\u2013383. doi: 10.1016/j.ejmech.2013.08.048.", "ArticleIdList": ["10.1016/j.ejmech.2013.08.048", "24077528"]}, {"Citation": "Ghorab MM, Ragab FA, Heiba HI, Nissan YM, Ghorab WM. Novel brominated quinoline and pyrimidoquinoline derivatives as potential cytotoxic agents with synergistic effects of \u03b3-radiation. Arch Pharm Res. 2012;35:1335\u20131346. doi: 10.1007/s12272-012-0803-6.", "ArticleIdList": ["10.1007/s12272-012-0803-6", "22941476"]}, {"Citation": "Ghorab MM, Alsaid MS, Nissan YM. Dapson in heterocyclic chemistry, part V: synthesis, molecular docking and anticancer activity of some novel sulfonylbiscompounds carrying biologically active dihydropyridine, dihydroisoquinoline, 1,3-dithiolan, 1,3-dithian, acrylamide, pyrazole, pyrazolopyrimidine and benzochromenemoieties. Chem Pharm Bull. 2012;60:1019\u20131028. doi: 10.1248/cpb.c12-00292.", "ArticleIdList": ["10.1248/cpb.c12-00292", "22863706"]}, {"Citation": "Ghorab MM, Ceruso M, AlSaid MS, Nissan YM, Arafa RK, Supuran CT. Novel sulfonamides bearing pyrrole and pyrrolopyrimidine moieties as carbonic anhydrase inhibitors: synthesis, cytotoxic activity and molecular modeling. Eur J Med Chem. 2014;87:186\u2013196. doi: 10.1016/j.ejmech.2014.09.059.", "ArticleIdList": ["10.1016/j.ejmech.2014.09.059", "25255434"]}, {"Citation": "Ghorab MM, Ceruso M, AlSaid MS, Nissan YM, Supuran CT. Carbonic anhydrase inhibitors: synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties. Biooorg Med Chem. 2014;22:3684\u20133695. doi: 10.1016/j.bmc.2014.05.009.", "ArticleIdList": ["10.1016/j.bmc.2014.05.009", "24878360"]}, {"Citation": "Ghorab MM, Alsaid MS, Nissan YM. Anti breast cancer of some novel pyrrolo and pyrrolopyrimidine derivatives bearing a biologically active sulfonamide moiety. Life Sci J. 2013;10:2170\u20132183."}, {"Citation": "Ghorab MM, Alsaid MS, Nissan YM. Synthesis and molecular docking of some novel anticancer sulfonamides carrying a biologically active pyrrole and pyrrolopyrimidine moieties. Acta Pol Pharmaceutica. 2014;71:603\u2013614.", "ArticleIdList": ["25272886"]}, {"Citation": "Ferrer R, Lobo G, Gamboa N, Rodrigues J, Abramjuk C, Jung K, Leien M, Charris JE. Synthesis of [(7-Chloroquinolin-4-yl)amino]chalcones: potential antimalarial and anticancer agents. Sci Pharm. 2009;77:725. doi: 10.3797/scipharm.0905-07.", "ArticleIdList": ["10.3797/scipharm.0905-07"]}, {"Citation": "Ghorab MM, AlSaid MS, Ghabbour HA, Fun H. Design, synthesis, X-ray crystallographic study and anticancer activity of novel 4-(7-chloro-1-methylquinolin-4-(1H)-ylideneamino)-phenyl-3-(dimethylamino)-prop-2-en-1- Asian J Chem. 2014;26:8497\u20138500."}, {"Citation": "Maira SM. PI3K inhibitors for cancer treatment: five years of preclinical and clinical research after BEZ235. Mol Cancer Ther. 2016;2011:10.", "ArticleIdList": ["22072802"]}, {"Citation": "Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990;82:1107\u20131112. doi: 10.1093/jnci/82.13.1107.", "ArticleIdList": ["10.1093/jnci/82.13.1107", "2359136"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "12", "Day": "31"}, {"Year": "2016", "Month": "3", "Day": "22"}, {"Year": "2016", "Month": "4", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "4", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "4", "Day": "8", "Hour": "6", "Minute": "1"}, {"Year": "2016", "Month": "4", "Day": "5"}], "PublicationStatus": "epublish", "ArticleIdList": ["27053947", "PMC4822229", "10.1186/s13065-016-0164-1", "164"]}}], "PubmedBookArticle": []}